MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.

Angelo J Casa, Robert K Dearth, Beate C Litzenburger, Adrian V Lee, Xiaojiang Cui, The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance Frontiers in Bioscience. ,vol. Volume, pp. 3273- 3287 ,(2008) , 10.2741/2925

Liqiang Song, Yan Li, Weina Li, Shouzhen Wu, Zhikui Li, miR-495 Enhances the Sensitivity of Non-Small Cell Lung Cancer Cells to Platinum by Modulation of Copper-Transporting P-type Adenosine Triphosphatase A (ATP7A) Journal of Cellular Biochemistry. ,vol. 115, pp. 1234- 1242 ,(2014) , 10.1002/JCB.24665

Jae Yong Ryu, Hyun Uk Kim, Sang Yup Lee, Human genes with a greater number of transcript variants tend to show biological features of housekeeping and essential genes. Molecular BioSystems. ,vol. 11, pp. 2798- 2807 ,(2015) , 10.1039/C5MB00322A

Juanjuan Shan, Junjie Shen, Limei Liu, Feng Xia, Chuan Xu, Guangjie Duan, Yanmin Xu, Qinghua Ma, Zhi Yang, Qianzhen Zhang, Leina Ma, Jia Liu, Senlin Xu, Xiaochu Yan, Ping Bie, Youhong Cui, Xiu-wu Bian, Cheng Qian, Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. Hepatology. ,vol. 56, pp. 1004- 1014 ,(2012) , 10.1002/HEP.25745

Yanmin Xu, Feng Xia, Leina Ma, Juanjuan Shan, Junjie Shen, Zhi Yang, Jia Liu, Youhong Cui, Xiuwu Bian, Ping Bie, Cheng Qian, MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest Cancer Letters. ,vol. 310, pp. 160- 169 ,(2011) , 10.1016/J.CANLET.2011.06.027

Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme De Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner, Myron Schwartz, Camillo Porta, Stefan Zeuzem, Luigi Bolondi, Tim F Greten, Peter R Galle, Jean-François Seitz, Ivan Borbath, Dieter Häussinger, Tom Giannaris, Minghua Shan, Marius Moscovici, Dimitris Voliotis, Jordi Bruix, None, Sorafenib in Advanced Hepatocellular Carcinoma The New England Journal of Medicine. ,vol. 359, pp. 378- 390 ,(2008) , 10.1056/NEJMOA0708857

Alessandro Vitale, Michael L. Volk, Davide Pastorelli, Sara Lonardi, Fabio Farinati, Patrizia Burra, Paolo Angeli, Umberto Cillo, Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology. ,vol. 51, pp. 165- 173 ,(2010) , 10.1002/HEP.23260

Huban Kutay, Shoumei Bai, Jharna Datta, Tasneem Motiwala, Igor Pogribny, Wendy Frankel, Samson T. Jacob, Kalpana Ghoshal, Downregulation of miR‐122 in the rodent and human hepatocellular carcinomas Journal of Cellular Biochemistry. ,vol. 99, pp. 671- 678 ,(2006) , 10.1002/JCB.20982

Nikolaos A. Dallas, Ling Xia, Fan Fan, Michael J. Gray, Puja Gaur, George van Buren, Shaija Samuel, Michael P. Kim, Sherry J. Lim, Lee M. Ellis, Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition Cancer Research. ,vol. 69, pp. 1951- 1957 ,(2009) , 10.1158/0008-5472.CAN-08-2023

Sylvia K. Shenouda, Suresh K. Alahari, MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer and Metastasis Reviews. ,vol. 28, pp. 369- 378 ,(2009) , 10.1007/S10555-009-9188-5